Frazier Life Sciences SPAC II Prices $75M IPO at $10.00/Share
FLSC is trading near its 52-week low of $10.18 (1.1% above the low).
Summary
Frazier Life Sciences Acquisition Corp. II priced its $75 million SPAC IPO at $10.00 per share, with the sponsor holding founder shares acquired at a nominal $0.013 per share — a structure that creates immediate dilution for public investors.
Key Events · Financing and Capital Events · FLSC
-
$75M SPAC IPO Priced
7,500,000 Class A ordinary shares offered at $10.00 per share for $75,000,000 gross proceeds, with $75,000,000 deposited into a trust account.
-
Sponsor Founder Share Dilution
Sponsor acquired 1,875,000 founder shares for $25,000 (~$0.013/share). At a $72M trust valuation, implied value per share is $7.44 — a 26% decrease from the $10.00 offering price.
-
Forward Purchase Commitment
FLSPF committed to purchase a minimum of 2,500,000 shares at $10.00 ($25,000,000) in a private placement closing concurrently with the initial business combination.
-
Underwriting Terms
Jefferies LLC is sole book-running manager. Total underwriting commission is $0.60/share ($4.5M), including $0.40/share deferred ($3.0M) payable only upon business combination completion.
Analysis · FLSC · Energy & Transportation
Frazier Life Sciences Acquisition Corp. II, a blank check company sponsored by Frazier Life Sciences, has finalized terms for its $75 million initial public offering. The company will sell 7.5 million Class A ordinary shares at $10.00 each, with $75 million deposited into a trust account. The sponsor, Frazier Life Sciences Holdings II LLC, is simultaneously purchasing 300,000 private placement shares for $3 million, and FLSPF has committed to a forward purchase of at least 2.5 million shares ($25 million) upon completion of a business combination. The sponsor acquired 1.875 million founder shares for just $25,000 (~$0.013 per share), creating immediate and material dilution for public shareholders — the prospectus discloses an implied value of $7.44 per share at a $72 million trust valuation, a 26% decrease from the $10.00 offering price. The company has 24 months to complete a business combination, targeting life sciences and biotechnology companies.
How filings like this one have moved
In the 30 days to Oct 14, 2026, 28.8% of the 1461 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.47%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, FLSC was trading at $10.29 on NASDAQ in the Energy & Transportation sector. The 52-week trading range was $10.18 to $10.41. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.